These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 16145051)
1. Genomic instability of human mammary epithelial cells overexpressing a truncated form of EMSY. Raouf A; Brown L; Vrcelj N; To K; Kwok W; Huntsman D; Eaves CJ J Natl Cancer Inst; 2005 Sep; 97(17):1302-6. PubMed ID: 16145051 [TBL] [Abstract][Full Text] [Related]
5. EMSY and CCND1 amplification in familial breast cancer: from the Ontario site of the Breast Cancer Family Registry. Bane AL; Mulligan AM; Pinnaduwage D; O'Malley FP; Andrulis IL Breast Cancer Res Treat; 2011 Jun; 127(3):831-9. PubMed ID: 21327470 [TBL] [Abstract][Full Text] [Related]
6. Amplification of the BRCA2 pathway gene EMSY in sporadic breast cancer is related to negative outcome. Rodriguez C; Hughes-Davies L; Vallès H; Orsetti B; Cuny M; Ursule L; Kouzarides T; Theillet C Clin Cancer Res; 2004 Sep; 10(17):5785-91. PubMed ID: 15355907 [TBL] [Abstract][Full Text] [Related]
7. Expression of EMSY, a novel BRCA2-link protein, is associated with lymph node metastasis and increased tumor size in breast carcinomas. Madjd Z; Akbari ME; Zarnani AH; Khayamzadeh M; Kalantari E; Mojtabavi N Asian Pac J Cancer Prev; 2014; 15(4):1783-9. PubMed ID: 24641409 [TBL] [Abstract][Full Text] [Related]
8. The protein kinase Akt1 regulates the interferon response through phosphorylation of the transcriptional repressor EMSY. Ezell SA; Polytarchou C; Hatziapostolou M; Guo A; Sanidas I; Bihani T; Comb MJ; Sourvinos G; Tsichlis PN Proc Natl Acad Sci U S A; 2012 Mar; 109(10):E613-21. PubMed ID: 22315412 [TBL] [Abstract][Full Text] [Related]
9. Co-amplification of CCND1 and EMSY is associated with an adverse outcome in ER-positive tamoxifen-treated breast cancers. Brown LA; Johnson K; Leung S; Bismar TA; Benítez J; Foulkes WD; Huntsman DG Breast Cancer Res Treat; 2010 Jun; 121(2):347-54. PubMed ID: 19636701 [TBL] [Abstract][Full Text] [Related]
10. EMSY promoted the growth and migration of ovarian cancer cells. Zhao X; Zhou Y; Nie M; Xian S; Chen H; Wen Y; Zhang L; Huang Y; Chen M; Wang S Tumour Biol; 2015 Apr; 36(4):3085-92. PubMed ID: 25510665 [TBL] [Abstract][Full Text] [Related]
11. Germline EMSY sequence alterations in hereditary breast cancer and ovarian cancer families. Määttä KM; Nurminen R; Kankuri-Tammilehto M; Kallioniemi A; Laasanen SL; Schleutker J BMC Cancer; 2017 Jul; 17(1):496. PubMed ID: 28738860 [TBL] [Abstract][Full Text] [Related]
12. The BRCA2-EMSY connection: implications for breast and ovarian tumorigenesis. Haber DA Cell; 2003 Nov; 115(5):507-8. PubMed ID: 14651841 [TBL] [Abstract][Full Text] [Related]
14. The EMSY threonine 207 phospho-site is required for EMSYdriven suppression of DNA damage repair. Jelinic P; Eccles LA; Tseng J; Cybulska P; Wielgos M; Powell SN; Levine DA Oncotarget; 2017 Feb; 8(8):13792-13804. PubMed ID: 28099152 [TBL] [Abstract][Full Text] [Related]
15. Genetic alterations of CCND1 and EMSY in breast cancers. Kirkegaard T; Nielsen KV; Jensen LB; Campbell FM; Müller S; Tovey SM; Brown S; Cooke TG; Bartlett JM Histopathology; 2008 May; 52(6):698-705. PubMed ID: 18393977 [TBL] [Abstract][Full Text] [Related]
16. EMSY copy number variation in male breast cancers characterized for BRCA1 and BRCA2 mutations. Navazio AS; Rizzolo P; Silvestri V; Valentini V; Zelli V; Zanna I; Masala G; Bianchi S; Tommasi S; Palli D; Ottini L Breast Cancer Res Treat; 2016 Nov; 160(1):181-186. PubMed ID: 27628328 [TBL] [Abstract][Full Text] [Related]
17. Amplification of EMSY, a novel oncogene on 11q13, in high grade ovarian surface epithelial carcinomas. Brown LA; Irving J; Parker R; Kim H; Press JZ; Longacre TA; Chia S; Magliocco A; Makretsov N; Gilks B; Pollack J; Huntsman D Gynecol Oncol; 2006 Feb; 100(2):264-70. PubMed ID: 16236351 [TBL] [Abstract][Full Text] [Related]
18. Functional characterization of EMSY gene amplification in human cancers. Wilkerson PM; Dedes KJ; Wetterskog D; Mackay A; Lambros MB; Mansour M; Frankum J; Lord CJ; Natrajan R; Ashworth A; Reis-Filho JS J Pathol; 2011 Sep; 225(1):29-42. PubMed ID: 21735447 [TBL] [Abstract][Full Text] [Related]
19. The function of EMSY in cancer development. Hou J; Wang Z; Yang L; Guo X; Yang G Tumour Biol; 2014 Jun; 35(6):5061-6. PubMed ID: 24609898 [TBL] [Abstract][Full Text] [Related]
20. A novel BRCA2-binding protein and breast and ovarian tumorigenesis. King MC N Engl J Med; 2004 Mar; 350(12):1252-3. PubMed ID: 15028830 [No Abstract] [Full Text] [Related] [Next] [New Search]